FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer

NCT00646607 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3756

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: FOLFOX (Oxaliplatin, 5Fluorouracil, Lederfolin)
DRUG: FOLFOX (Oxaliplatin, 5Fluorouracil, Lederfolin)

Sponsor

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Collaborators

[object Object]